Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimixia-M 2 Tablet ER is to be taken with food. Glimixia-M 2 Tablet ER may cause stomach upset if taken empty stomach.
Glimixia-M 2 Tablet ER is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.
Taking metformin with alcohol can cause lactic acidosis and you may experience malaise, respiratory distress, slow or irregular heartbeat, sleepiness, stomach upset, or other unusual symptoms.
WEIGH RISKS VS BENEFITS
Glimixia-M 2 Tablet ER may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Glimixia-M 2 Tablet ER is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Your ability to drive may be affected if your blood sugar is low or high. If this happens, do not drive.
Glimixia-M 2 Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Glimixia-M 2 Tablet ER may be needed. Please consult your doctor. Use of Glimixia-M 2 Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Glimixia-M 2 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Glimixia-M 2 Tablet ER may be needed. Please consult your doctor. Glimixia-M 2 Tablet ER is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.